Divi's Laboratories share news and announcements
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.
52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
- Next results date: the board meets on 7 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,37,594 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 1 Aug 2026
- 81.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 14.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 1 Aug 2026
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 1 Aug 2026
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,20,26160.6% delivered
Divi's Laboratories board meetings
113 filed, newest first. Page 3 of 3.
Oct 2008
17 Oct · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the second quarter ended September 30, 2008.
Jul 2008
17 Jul · Board meeting
Inter-alia, to consider and approve the un-audited financial results for the quarter ended June 30, 2008.
May 2008
29 May · Board meeting
Company had informed the Exchange that a Meeting of the Board of Directors of the Company will be held on June 06, 2008 inter-alia, to consider and approve the audited financial results for the year ended March 31, 2008 and dividend on equity shares, if any, for the year. The Company has now informed the Exchange that the meeting of the Board of Directors of the Company has been postponed to June 07, 2008.28 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2008 and dividend on equity shares, if any, for the year.
Apr 2008
21 Apr · Board meeting
Compensation Committee of Board of Directors in its meeting held on 19th April 2008 made the allotment of 115850 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64672950 equity shares from 64557100 equity shares of face value Rs. 2/- each.15 Apr · Board meeting
Meeting of the Compensation Committee is scheduled to be held on April 19, 2008, to allot the equity shares to employees in pursuance of the ESOP 2006.
Jan 2008
19 Jan · Board meeting
Meeting on 28 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
18 Oct · Board meeting
Meeting on 27 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Jul 2007
20 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
May 2007
15 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2007.
Mar 2007
19 Mar · Board meeting
Board of Directors in its meeting held on 17th March 2007 declared an interim dividend @ 100% (Rs.10/- per share) on Equity Capital of the Company for the financial year 2006-07 to all the Equity shareholders whose names appear in the Register of Members of the Company on 26th March 2007 being the record date fixed for the purpose of payment of aforesaid dividend12 Mar · Board meeting
Inter-alia to consider and declare interim dividend on Equity Shares of the Company for the year ended 31st March, 2007 and if declared in the said Board meeting, 26th March, 2007 has been fixed as the record date for the purpose of payment of aforesaid dividend.
Jan 2007
19 Jan · Board meeting
Meeting on 27 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”